The ImmunoSABR project is consortium of 15 partners which has been created from leading Institutes within the EU . Working together their aim is to open up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy.

University College London

University College London Cancer Institute and the University College Hospital form a leading UK Comprehensive Cancer Centre, combining basic cancer [...]

Universitair Ziekenhuis Gent

UZ Gent is one of the largest and most specialized hospitals in Flanders, delivering a full range of highly specialized, [...]

Universitaets Klinikum Tuebingen

We are an academic tertiary care center treating 2500 new cancer patients per year (>45000 fractions). Our clinical and scientific [...]


The Università Cattolica del Sacro Cuore  is the most comprehensive and complete legally recognized university in Italy: it includes five [...]

Technische Universität Dresden

OncoRay is an interdisciplinary research center established in 2005 and financed by the Technische Universität Dresden, the University Hospital Dresden [...]


Radboud university medical center is a leading academic center for patient care, education and research, with the mission ‘to have [...]

Philogen S.p.A

Philogen ( was founded in 1996 with the mission to develop new bio- pharmaceuticals for the treatment of angiogenesis-related disorders, [...]


The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) is an integrated comprehensive cancer centre, combining a hospital and [...]

Maastricht UMC +

The University of Maastricht (UM) and the University Medical Center Maastricht (azM) work together under the umbrella organisation Maastricht UMC+, [...]


The Leuven Lung Cancer Group (LLCG) is a world- wide recognised high-quality clinical and experimental hub in which innovative diagnosis [...]

Health Innovation Ventures B.V.

Health Innovation Ventures B.V. aims to revolutionise healthcare through several approaches. Specifically, two departments of Health Innovation V entures will [...]


If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.




The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands


This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008

Go to Top